(R)-(+)-Warfarin
SIGMA/UC213 - ≥97% (HPLC)
Synonym: R-
CAS Number: 5543-58-8
Empirical Formula (Hill Notation): C19H16O4
Molecular Weight: 308.33
EC Number: 226-908-9
MDL Number: MFCD00272376
Linear Formula: C19H16O4
Product Type: Chemical
assay | ≥97% (HPLC) |
color | white to pale yellow |
form | solid |
InChI | 1S/C19H16O4/c1-12(20)11-1 |
InChI key | PJVWKTKQMONHTI-OAHLLOKOSA |
mp | ≥170 °C |
Quality Level | 200 |
SMILES string | [H][C@@](CC(C)=O)(c1ccccc |
solubility | DMF: soluble |
DMSO: soluble | |
ethanol: soluble | |
storage temp. | 2-8°C |
Application: | (R)-(+)-warfarin has been used to investigate whether enantiomers of warfarin stereoselectively interact with pregnane X nuclear receptor (PXR) to upregulate main drug/xenobiotic-metaboliz |
Biochem/physiol Actions: | CYP1A2/3A4 substrate; anticoagulant. |
Biochem/physiol Actions: | Warfarin acts as a vitamin K antagonist. It is widely used to treat thromboembolic disorders. (R)-warfarin interacts with pregnane X receptor (PXR) and induces cytochrome P450 3A4 (CYP3A4) and CYP2C9 mRNAs expression in primary human hepatocyte cultures. |
General description: | The chiral carbon at position 9 produces two enantiomers, R- and S-warfarin. Commercially available warfarin (Coumadin or Jantoven) is a racemic mixture of S- and R-enantiomers. |
Packaging: | 10 mg in glass bottle |
Packaging: | Bottomless glass bottle. Contents are inside inserted fused cone. |
Preparation Note: | (+)-Warfarin is soluble in DMF, DMSO and ethanol. |
Symbol | GHS08 |
Signal word | Danger |
Hazard statements | H360D - H372 - H412 |
Precautionary statements | P201 - P273 - P308 + P313 |
Hazard Codes | T |
Risk Statements | 61-48/25-52/53 |
Safety Statements | 53-45-61 |
RIDADR | UN 2811 6.1 / PGI |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥97% (HPLC) |
mp | ≥170 °C |
Storage Temp. | 2-8°C |
UNSPSC | 12161501 |